GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Science Strategic Acquisition Corp Alpha (NAS:SSAAU) » Definitions » COGS-to-Revenue

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) COGS-to-Revenue : 0.00 (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Science Strategic Acquisition Alpha COGS-to-Revenue?

Science Strategic Acquisition Alpha's Cost of Goods Sold for the three months ended in Sep. 2022 was $0.00 Mil. Its Revenue for the three months ended in Sep. 2022 was $0.00 Mil.

Science Strategic Acquisition Alpha's COGS to Revenue for the three months ended in Sep. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Science Strategic Acquisition Alpha's Gross Margin % for the three months ended in Sep. 2022 was N/A%.


Science Strategic Acquisition Alpha COGS-to-Revenue Historical Data

The historical data trend for Science Strategic Acquisition Alpha's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Science Strategic Acquisition Alpha COGS-to-Revenue Chart

Science Strategic Acquisition Alpha Annual Data
Trend Dec20 Dec21
COGS-to-Revenue
- -

Science Strategic Acquisition Alpha Quarterly Data
Oct20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
COGS-to-Revenue Get a 7-Day Free Trial - - - - -

Science Strategic Acquisition Alpha COGS-to-Revenue Calculation

Science Strategic Acquisition Alpha's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Science Strategic Acquisition Alpha's COGS to Revenue for the quarter that ended in Sep. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Science Strategic Acquisition Alpha  (NAS:SSAAU) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Science Strategic Acquisition Alpha's Gross Margin % for the three months ended in Sep. 2022 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Science Strategic Acquisition Alpha COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Science Strategic Acquisition Alpha's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Business Description

Traded in Other Exchanges
N/A
Address
1447 2nd Street, Suite 200, Santa Monica, CA, USA, 90401
Science Strategic Acquisition Corp Alpha is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
Executives
Michael Gwynne Jones director, officer: CEO 24460 MALIBU ROAD, MALIBU CA 90265
Jeff Kearl director C/O SKULLCANDY, INC., 1441 WEST UTE BLVD., SUITE 250, PARK CITY UT 84908
April Henry officer: EVP, Corporate Development C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Jennifer Rubio director C/O TISHMAN SPEYER PROPERTIES, L.P., ROCKEFELLER CENTER, 45 ROCKEFELLER PLAZA, NEW YORK NY 10111
Taylor Colette K. director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Greg Gilman director C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Priscilla Guevara officer: Global Head of IR C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Tom Dare officer: CFO C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401
Peter Pham officer: President C/O SCIENCE STRATEGIC ACQUISITION CORP., 1447 2ND STREET, SANTA MONICA CA 90401

Science Strategic Acquisition Alpha (Science Strategic Acquisition Alpha) Headlines

No Headlines